Nuveen LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Nuveen LLC has acquired over 2 million shares of Option Care Health, representing an investment worth approximately $70.97 million, which constitutes about 1.24% of the company.
• Several institutional investors are increasing their stakes in Option Care Health, with notable increases including Allspring Global Investments growing its holdings by over 6,525,926%.
• Analysts generally have a positive outlook on Option Care Health, with eight analysts giving a buy rating and a consensus price target of $35.75 for its shares.

Nuveen LLC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,030,463 shares of the company's stock, valued at approximately $70,965,000. Nuveen LLC owned approximately 1.24% of Option Care Health as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Compass Wealth Management LLC increased its stake in Option Care Health by 8.9% in the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after buying an additional 13,600 shares in the last quarter. Bessemer Group Inc. increased its stake in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares in the last quarter. Principal Financial Group Inc. increased its stake in Option Care Health by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after buying an additional 6,616 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Option Care Health by 25.7% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after buying an additional 1,691 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in Option Care Health by 307.1% in the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock worth $112,000 after buying an additional 2,408 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Trading Down 0.3%

OPCH traded down $0.09 on Friday, hitting $28.32. The company had a trading volume of 1,179,882 shares, compared to its average volume of 1,593,526. The company has a market cap of $4.60 billion, a PE ratio of 22.66, a PEG ratio of 1.80 and a beta of 0.79. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The business's fifty day simple moving average is $30.29 and its 200 day simple moving average is $31.85.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm's revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the business posted $0.30 earnings per share. Equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.